MedscapeTV • Going the Distance With Metastatic Breast Cancer - Episode 1: The Journey Begins
To watch the entire series please click here: https://www.medscape.com/mtv/metastatic-breast-cancer-s01?&faf=1
About this Series
Hormone receptor–positive is the most common breast cancer, accounting for approximately 80% of all cases. Although metastatic HR+/HER2- breast cancer remains incurable, it is increasingly manageable. Expanded treatment options, including targeted agents used in combination with endocrine therapy, are extending the lives of women with metastatic breast cancer, and careful monitoring of biomarkers helps indicate when it is appropriate to change therapies. Increased emphasis on diet and exercise, psychosocial support, and symptom management—especially of bone metastases—contributes to an increased quality of life for women with metastatic disease.
Experts at Dana-Farber Cancer Institute discuss the ways in which treatment of HR+/HER2- metastatic breast cancer is evolving into an individualized approach, and how metastatic breast cancer patients are taking an active role as partners in the research of their disease.
Видео MedscapeTV • Going the Distance With Metastatic Breast Cancer - Episode 1: The Journey Begins канала Medscape
About this Series
Hormone receptor–positive is the most common breast cancer, accounting for approximately 80% of all cases. Although metastatic HR+/HER2- breast cancer remains incurable, it is increasingly manageable. Expanded treatment options, including targeted agents used in combination with endocrine therapy, are extending the lives of women with metastatic breast cancer, and careful monitoring of biomarkers helps indicate when it is appropriate to change therapies. Increased emphasis on diet and exercise, psychosocial support, and symptom management—especially of bone metastases—contributes to an increased quality of life for women with metastatic disease.
Experts at Dana-Farber Cancer Institute discuss the ways in which treatment of HR+/HER2- metastatic breast cancer is evolving into an individualized approach, and how metastatic breast cancer patients are taking an active role as partners in the research of their disease.
Видео MedscapeTV • Going the Distance With Metastatic Breast Cancer - Episode 1: The Journey Begins канала Medscape
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Innovation in Cardiology | Linkedin LIVEShould Aspirin Be the Second-Line Antiplatelet in CAD?3D Printing of Complex Orthopedic Implants Fills Niche RoleMedscape TV Presents: Colorectal Cancer in Young People, Part IHope Is Fine, but Reality Is Best in End-of-Life CareCutting Edge Developments in Hereditary Angioedema: Insights Into 2024 EAACINEW! Medscape TV Premier: Confronting Insulin'Remember Why We Went Into This': Balancing the Dark Days in Oncology | ASCO 2019Adult Vaccines 2022: Who Needs What, and When?Why Facebook Doesn't Really Help Diagnose DiabetesMedscapeTV • Dry Eye: A Clinical Focus - Episode 1: An Uncanny MimicMonkeypox: What Do Experts Actually Think?New Pediatric Advanced Life Support Guidelines Raise QuestionsAntiseizure Meds and Cardiovascular RiskShould ADAURA Trial Results Change Practice in NSCLC?Value of Simulation | Medscape EducationFrontal Lobe Spike, Fake Smiling, Device for DVT | The Week That Wasn'tTop 10 Advances in Thoracic Oncology in 2020Patient's google searches, learning in your sleep, more anti-vaxers | The Week that Wasn'tTackling the Tough Questions on TAAR1 in Schizophrenia: A Live Social Media Event